VERACYTE, INC. (VCYT) Gross Margin
- Gross margin · 12 months: Value 71.71%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 71.71% | Gross profit / revenue. Period ending 2026-06-30. $402.96M ÷ $561.90M × 100 ≈ 71.71% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 402.96M USD | Gross Profit |
| Revenue | 561.90M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $402.96M | $561.90M | (m) | 71.71% |
| 2026-03-31 | $384.18M | $541.74M | (m) | 70.92% |
| 2025-12-31 | $362.53M | $517.14M | (m) | 70.10% |
| 2025-09-30 | $339.31M | $495.14M | (m) | 68.53% |
| 2025-06-30 | $327.04M | $479.13M | (m) | 68.26% |
| 2025-03-31 | $315.19M | $463.39M | (m) | 68.02% |
| 2024-12-31 | $298.14M | $445.76M | (m) | 66.88% |
| 2024-09-30 | (m) | $425.33M | (m) | (m) |
| 2024-06-30 | (m) | $399.58M | (m) | (m) |
| 2024-03-31 | (m) | $375.47M | (m) | (m) |
| 2023-12-31 | (m) | $361.05M | (m) | (m) |
| 2023-09-30 | (m) | $343.15M | (m) | (m) |
| 2023-06-30 | (m) | $328.63M | (m) | (m) |
| 2023-03-31 | (m) | $311.18M | (m) | (m) |
| 2022-12-31 | (m) | $296.54M | (m) | (m) |
| 2022-09-30 | (m) | $283.57M | (m) | (m) |
| 2022-06-30 | (m) | $268.35M | (m) | (m) |
| 2022-03-31 | (m) | $250.59M | (m) | (m) |
| 2021-12-31 | (m) | $219.51M | (m) | (m) |
| 2021-09-30 | (m) | $186.71M | (m) | (m) |
| 2021-06-30 | (m) | $157.47M | (m) | (m) |
| 2021-03-31 | (m) | $123.06M | (m) | (m) |
| 2020-12-31 | (m) | $117.48M | (m) | (m) |
| 2020-09-30 | (m) | $112.68M | (m) | (m) |
| 2020-06-30 | (m) | $112.53M | (m) | (m) |
| 2020-03-31 | (m) | $121.96M | (m) | (m) |
| 2019-12-31 | (m) | $120.37M | (m) | (m) |
| 2019-09-30 | (m) | $116.39M | (m) | (m) |
| 2019-06-30 | (m) | $108.88M | (m) | (m) |
| 2019-03-31 | (m) | $101.50M | (m) | (m) |
| 2018-12-31 | (m) | $92.01M | (m) | (m) |
| 2018-09-30 | (m) | $85.85M | (m) | (m) |
| 2018-06-30 | (m) | $79.91M | (m) | (m) |
| 2018-03-31 | (m) | $75.56M | (m) | (m) |
| 2017-12-31 | (m) | $71.95M | (m) | (m) |
| 2017-09-30 | (m) | $70.61M | (m) | (m) |
| 2017-06-30 | (m) | $71.70M | (m) | (m) |
| 2017-03-31 | (m) | $67.97M | (m) | (m) |
| 2016-12-31 | (m) | $65.08M | (m) | (m) |
| 2016-09-30 | (m) | $60.87M | (m) | (m) |
| 2016-06-30 | (m) | $54.60M | (m) | (m) |
| 2016-03-31 | (m) | $51.84M | (m) | (m) |
| 2015-12-31 | (m) | $49.50M | (m) | (m) |
| 2015-09-30 | (m) | $47.66M | (m) | (m) |
| 2015-06-30 | (m) | $45.16M | (m) | (m) |
| 2015-03-31 | (m) | $41.93M | (m) | (m) |
| 2014-12-31 | (m) | $38.19M | (m) | (m) |
| 2014-09-30 | (m) | $32.83M | (m) | (m) |
| 2014-06-30 | (m) | $28.59M | (m) | (m) |
| 2014-03-31 | (m) | $24.98M | (m) | (m) |
| 2013-12-31 | (m) | $21.88M | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $17.13M | (m) | (m) |
| 2013-03-31 | (m) | $14.54M | (m) | (m) |
| 2012-12-31 | (m) | $11.63M | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $2.65M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |